Racial Disparities in Late Survival after Rectal Cancer Surgery
- 31 December 2006
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 203 (6) , 787-794
- https://doi.org/10.1016/j.jamcollsurg.2006.08.005
Abstract
African-American patients experience higher mortality than Caucasian patients after surgery for most common cancer types. Whether longterm survival after rectal cancer surgery varies by race is less clear. Using 1992 to 2003 Surveillance, Epidemiology, and End Results (SEER)-Medicare data, we examined race and longterm survival among African-American and Caucasian rectal cancer patients undergoing resection. We identified racial differences in patient characteristics, structure, and processes of care. We then assessed mortality using a Cox proportional hazards model, sequentially adding variables to explore the extent to which they attenuated the association between race and mortality. African-American patients had a substantially poorer overall survival rate than Caucasian patients did. Five-year survival rates were 41% and 50%, respectively (p < 0.0001). African Americans were younger (p=0.006), more likely to reside in low income areas (p < 0.0001), and had more baseline comorbid disease (p < 0.0001). They were also more likely to be diagnosed emergently (p < 0.001) and with more advanced cancer (p < 0.001). Accounting for demographic and clinical characteristics reduced the mortality difference, although it remained pronounced (hazard ratio=1.13, CI=1.01 to 1.26). African Americans were more likely to be treated by low volume surgeons and less likely to receive adjuvant therapy (48.6% versus 60.9%, p < 0.0001). After adjusting for provider variables, the hazard ratio for mortality by race was additionally attenuated and became statistically nonsignificant (hazard ratio=1.05, CI=0.92 to 1.20). Poorer longterm survival after rectal cancer surgery among African Americans is explained by measurable differences in processes of care and patient characteristics. These data suggest that outcomes disparities could be reduced by strategies targeting earlier diagnosis and increasing adjuvant therapy use among African-American patients.Keywords
This publication has 44 references indexed in Scilit:
- Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999Urology, 2004
- Primary Care Physicians Who Treat Blacks and WhitesNew England Journal of Medicine, 2004
- Race, socioeconomic status and stage at diagnosis for five common malignanciesCancer Causes & Control, 2003
- Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35Cancer, 2002
- Racial differences in treatment and survival from early‐stage breast carcinomaCancer, 2002
- Impact of Referral Patterns on the Use of Chemotherapy for Lung CancerJournal of Clinical Oncology, 2002
- Disparities in cancer diagnosis and survivalCancer, 2001
- Racial Differences in the Treatment of Early-Stage Lung CancerNew England Journal of Medicine, 1999
- Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries.American Journal of Public Health, 1996
- Race, socioeconomic status, and other prognostic factors for survival from colo-rectal cancerJournal of Chronic Diseases, 1987